Today, Montse de Castellarnau, Scientific & Regulatory Affairs Officer at Asphalion, will be attending the “Workshop on support for orphan medicines development”. The workshop is organized by the EMA and it is aimed to facilitate the development of orphan medicines in neglected disease areas. The virtual event will highlight tools and incentives, such as Orphan designation, Protocol Assistance and the PRIME scheme.
Montse de Castellarnau is Medical writer at Asphalion and will participate in this workshop, where she will have the opportunity to interact with the EMA, as well as with stakeholders involved in orphan drugs development.
Asphalion has more than 20 years of experience on Regulatory procedures, and we can support Stakeholders throughout the drug development, including medicines for orphan diseases. If you would like to know more on how Asphalion can assist you, do not hesitate to contact us at info@asphalion.com.
La mejor actitud que podemos adoptar es la de trat...
El equipo de investigadores observó cambios en el...
El gen AtCDF3 promueve una mayor producción de az...
En nuestro post hablamos sobre este interesante tipo de célula del si...
Curapath se complace en reconocer el importante avance logrado por Mac...
